Boston
Albert is involved in a broad range of corporate legal engagements for high growth technology companies, including IPOs, follow-on public offerings, private and public company securities law compliance matters, public company disclosure obligations, venture financings, mergers and acquisitions, de-SPAC transactions and SPAC IPOs. He also regularly advises public and private companies and their boards of directors on corporate governance issues.
Albert's clients include public and private companies in technology, energy, automotive, Internet related industries, real estate, finance and the life sciences (including, among others, immuno-oncology, gene therapy, restorative cell therapy and medical device companies). He also represents underwriters in initial public offerings, follow-on offerings and PIPE offerings and venture capital firms in a variety of investment transactions.
Albert was named to the Deal’s Top Rising Stars 2021 list, which recognizes top new partners at U.S. law firms who are “doing spectacular work in the field of deal-making and who have continued to progress in their career despite the obstacles put in front of them.”
Washington DC
Behn advises gaming and gambling providers, large media companies, Fintech, blockchain and more traditional financial services participants, and other technology and consumer-focused companies on issues at the intersection of gaming, financial services, data privacy and governance and related regulatory areas. Clients turn to him for his ability to advise on the whole frame of issues they may encounter, and he is equally comfortable guiding emerging companies in the early stages of their lifecycles and mature, multinational public companies. Behn is at home in the courtroom – representing clients in cutting-edge gaming litigations, before regulatory bodies – helping the crypto industry address growing sanctions and other financial services obligations, and in the boardroom – assisting in the formation of significant commercial partnerships, brand licenses, acquisitions and other combinations.
サンフランシスコ
サンフランシスコ
Austin serves as a trusted advisor to founders, emerging growth companies, venture capital funds, and other strategic investors in a wide array of corporate matters in connection with planning and executing a variety of transactions. Primarily, including formation, early and late-stage venture funding rounds, corporate governance, fund formation, and investment matters. Austin specializes in helping companies in the blockchain/crypto space but also advises an array of companies across software, fintech, artificial intelligence, and digital media.
In addition to representing U.S. companies on domestic transactions, Austin represents companies across the United States, EMEA, and Asia.
Prior to joining Orrick, Austin spent time at Gunderson Dettmer, Inceptiv, and SSM. During law school, Austin worked at The Northern District of Texas, aiding the Chief Justice in various matters.
Washington DC
Thora works with medical device, pharmaceutical, biotech and digital health companies, helping them navigate the increasingly complex patchwork of state and federal health privacy laws. One client described her to the Legal 500 as a “very practical” advisor providing “exceptional guidance” on health information privacy and HIPAA compliance matters.
Her breadth and depth of experience enable Thora to assist clients in harnessing the power of artificial intelligence and executing data-sharing arrangements, all while protecting health data. As a result, Thora spends much of her time counseling pioneering startups and high-growth companies on responsible innovation in healthcare and life sciences.
Thora brings extensive experience counseling clients, including Fortune 500 companies and brick and mortar providers, on the Health Insurance Portability and Accountability Act (HIPAA) and other state and federal health privacy and regulatory compliance regimes including:
Thora routinely helps companies and large employers prepare for and respond to privacy and security incidents involving health information. She also defends clients in government investigations initiated by the OCR, OIG, DOJ, FTC and State AGs, among others.
Washington DC
Georgia also has extensive experience in assisting clients with product recalls, crisis management and government enforcement. Her practice in this sector includes assisting manufacturers, distributors, retailers and importers on all types of FDA regulated products including pharmaceuticals, medical devices and software, wearables, health and wellness products, cosmetics, cell and plant based foods, conventional foods, ag tech, compounded drugs, and dietary supplements.
Georgia’s deep experience and ability to provide practical guidance in FDA and FDA-adjacent regulatory matters allows her to work closely with innovative companies looking to minimize regulatory burdens and maximize U.S. marketing opportunities in the life science and health tech industry verticals. She also conducts regulatory due diligence for private equity and public company transactions involving life science, medtech and innovative companies.
Georgia is a frequent speaker at conferences and events who contributes regularly to leading trade and consumer media outlets.
New York; シリコン・バレー
New York; シリコン・バレー
Stephen’s practice focuses on the representation of life science, medical device, health IT, and other technology companies in transactional matters, including public and private financings, licensing, collaborations and strategic alliances, and mergers and acquisitions. He also represents venture capital firms in public and private financing transactions.
Stephen is recognized as a Leading Life Sciences Lawyer by LMG Life Sciences in their 2021/2022 rankings and short-listed as Venture Capital Attorney of the Year. He has served as a member of the Board of Tech Council of Maryland, the leading technology and life science association in that state, and of BayBio, Northern California’s leading life sciences association. Stephen is a frequent speaker on venture capital financings and served on the faculty at the 2005 and 2007 Emerging Entrepreneurs workshops at Stanford University.
Prior to joining Orrick, Stephen was a partner at Morrison & Foerster, Venture Law Group and Heller Ehrman. He began his legal practice as a litigator, focusing on securities and intellectual property. He also served as a law clerk to the Hon. Vaughn R. Walker in the United States District Court in the Northern District of California. Stephen graduated Order of the Coif from Stanford Law School, where he was managing editor of the Stanford Law Review, and graduated magna cum laude from Harvard College in Biology.
Washington DC
A substantial part of Shari’s practice involves aiding life sciences (pharma, medical device, and biologic) and healthcare companies with internal investigations and working with clients on compliance with government investigations, subpoenas, and investigative demands, as well as the defense of whistleblower qui tam suits involving the False Claims Act and the Anti-Kickback Statute. Shari has also managed litigations and helped lead trial teams involving diverse fields of science and technology including pharmaceuticals, various medical fields, and seals used in the semiconductor industry. She specializes in mastering complicated science and technologies and explaining them to judges and juries.
Shari regularly represents companies with FDA-regulated products and healthcare companies on strategic regulatory counseling matters. She also regularly conducts regulatory due diligence for private equity funds, acquirers, sellers, and underwriters in corporate transactions.
Shari also has substantial experience advising clients on complex advertising/promotion issues, including claim substantiation, disputes before the National Advertising Division of the BBB National Programs (NAD), and advertising lawsuits under Section 43(a) of the Lanham Act. She also regularly advises consumer product companies on Consumer Product Safety Commission related compliance.
Upon graduation from Harvard Law School, Shari clerked for the Honorable Frank A. Kaufman, United States District Court for the District of Maryland, who sat by designation on the U.S. Courts of Appeals for the Federal Circuit, the Fourth Circuit, the Seventh Circuit, and the Eleventh Circuit.
Boston
Tori advises clients on enhancing their data privacy and security profiles and building comprehensive global data protection programs. She provides guidance on issues relating to a vast array of state, federal and international privacy and cybersecurity laws, including:
Tori also supports clients in developing strategies to reduce the risk of security incidents, regularly advises on general consumer protection issues, and counsels on sweepstakes, marketing, and advertising matters.
Prior to joining Orrick, Tori served as an in-house data privacy and security law clerk at a pharmaceutical company in Boston, at a large nonprofit corporation in New York City, and at an international oil and gas company in Beijing. She also worked on data privacy matters in the Office of the General Counsel of Northeastern University. Having worked across diverse business sectors, including life sciences, technology and energy, Tori brings an in-house perspective to her client matters.
New York
Ben has a deep understanding of sanctions and AML regulations and enforcement. In addition to his client work, he has participated in numerous financial industry group regulatory initiatives related to sanctions and AML issues, including The Clearing House Guiding Principles for Anti-Money Laundering Policies and Procedures in Correspondent Banking, initiatives to address “de-risking” and related to BSA information sharing. Ben also conducts international trainings in AML and sanctions issues for the Financial Services Volunteer Corps.
He has been recognized by Best Lawyers in America as "One to Watch" and by Super Lawyers as a "Rising Star." Prior to joining Orrick, Ben was counsel at Buckley LLP and an associate at Sullivan & Cromwell LLP.
Washington DC
Elizabeth's experience includes work on internal investigations, voluntary disclosures, commodity jurisdiction requests and developing and implementing compliance programs. She also advises clients on government contracting matters.
シアトル
Aaron has defended criminal and civil enforcement actions by the U.S. Department of Justice, the Washington Attorney General's Office, and other state and federal agencies. He has also represented defendants in False Claims Act litigation initiated by private parties, as well as a broad range of other civil litigation. And he has conducted internal investigations on matters ranging from data breaches to harassment to suspected environmental testing fraud.
Washington DC
Harry is experienced in areas such as CFIUS/Exon-Florio examinations of foreign investment, military and “dual use” export control regulations (ITAR/EAR), economic sanctions administered by the U.S. Treasury Department (OFAC), customs regulations, the Foreign Corrupt Practices Act, anti-money laundering rules, anti-boycott requirements and defense industrial security requirements. He executes internal corporate investigations regarding trade and investment rules and advises on such rules in the context of corporate transactions.
Additionally, Harry has extensive experience with government contracting matters. His government contracting work has included, for example, design and implementation of U.S. Defense Department renewable energy projects. He also represents broad industry coalitions on major trade litigations and international negotiations. His experience in these areas includes a leading role in what is often considered the largest-ever international trade dispute: the controversy regarding unfair softwood lumber imports from Canada. It has involved myriad administrative proceedings before federal agencies, NAFTA panel appeals, WTO dispute proceedings, judicial proceedings and international settlement agreements.
Harry has represented a coalition of major U.S. oil companies in antidumping and countervailing duty litigation. As a related matter, he pursues policy issues with congressional and executive branch officials and advises on international trade rules (e.g., GATT, WTO agreements and NAFTA).
Chambers 2022 recognizes Harry as a leader in the field of export controls and economic sanctions (Chambers Global and Chambers USA), as well as CFIUS (Chambers USA). Previous editions have also recognized Harry’s achievements regarding his work related to the Foreign Corrupt Practices Act. Clients note that Harry provides “accurate, straightforward guidance incredibly efficiently” and “he has an ability to translate complex legal requirements and rules into business-friendly jargon.”